GILEAD SCIENCES, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.27 USD | -0.29% |
|
-0.95% | -19.90% |
| May. 07 | Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates | MT |
| May. 02 | UBS Adjusts Price Target on Gilead Sciences to $70 From $75, Maintains Neutral Rating | MT |
e6248d40.B7uccy6GpcIHuj7qsano0DoQ5nF1nQ1YQrQ_CrlcDRg.dfakIGKy_6Q_7Qiy6-qhklRJghlDyHsvCM1JfNYzbjVRyuU0bd-QulfoTQ~08c9243633df637b16bf82e1fcd68547